Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study. - van Baar ACG; Meiring S; Smeele P; Vriend T; Holleman F; Barlag M; Mostafavi N; Tijssen JGP; Soeters MR; Nieuwdorp M; Bergman JJGHM (Gastrointestinal endoscopy, 2021)